Long term (current) use of oral hypoglycemic drugs

This code indicates a patient's ongoing, regular use of oral medications designed to lower blood sugar levels. These drugs are typically prescribed for individuals with type 2 diabetes or other conditions requiring glycemic control, and their use is expected to continue for an extended period.

Apply this code when documenting a patient's current, continuous treatment with oral antidiabetic agents, such as metformin, sulfonylureas, or DPP-4 inhibitors. This is commonly used in conjunction with a diabetes diagnosis to fully capture the patient's treatment regimen.

• Do not use this code for patients taking injectable non-insulin antidiabetic drugs or insulin; refer to the specific exclusion notes.
• Always code the underlying condition, such as diabetes mellitus, first, followed by this code to indicate the long-term medication use.
• Ensure documentation clearly states the patient is currently and long-term using oral hypoglycemic agents.